New MRD Assessment Data Using clonoSEQ® To Be Presented at 2024 ASCO Annual Meeting and EHA2024 Hybrid Congress

Read More

Acalabrutinib with Rituximab As First-Line Therapy for Older Patients with Mantle Cell Lymphoma: a Phase II Clinical Trial

Read the latest from Adaptive

News Releases